Operator
Hello, everyone, and a warm welcome again to the Poland conference on air to those who attended some further calls. And now I’m delighted to welcome FamiCord AG and the CEO, Jakub Baran. So he will be the last presentation, but not the least. So now we are happy to see what FamiCord is doing. And yes, you will get us through some insights and the presentation, Jakub. So now the stage is yours.
Jakub Baran
Chairman of the Management Board & CEO
Thank you — thank you very much. Welcome, everybody. This time from our Warsaw office. I share my time between Leipzig and Warsaw. And I will tell you, I will walk you through a presentation of our company named FamiCord, which we believe is just something more than stem cell bank.
So first of all, why we are here at Poland ON AIR. A few years ago, Polish company called komorek macierzystych did a cross-border merger with German listed company called Vita 34 AG. And Vita at the time was listed at Deutsche Borse and we are listed at the Warsaw Stock Exchange. So at the time, Vita simply purchased PBKM, paying in shares and partially in cash. In fact, that transaction was a reversal takeover as PBKM was much larger company at the time and was by far the largest stem cell bank in Europe.
After that merger, which is pretty rare, and we think it’s rather even unique operations between mid-cap companies between Polish and German stock exchanges, PBKM was delisted from Warsaw Stock Exchange, and now we are listed only at
#FamiCord #Special #Call